Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06854328Not ApplicableRecruiting

The Prism Conformity Trial for Post-Traumatic Stress Disorder in Adolescents

Role: lead

NCT06982820Not ApplicableRecruiting

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Role: lead

NCT06770998Not ApplicableRecruiting

A Study of a Novel EEG Neurofeedback System for PTSD Treatment

Role: collaborator

NCT05869708Not ApplicableCompleted

PRISM Neurofeedback Training for MDD Anhedonic Patients

Role: lead

NCT04891614Not ApplicableCompleted

The PRISM Pilot Trial for Post-Traumatic Stress Disorder

Role: lead

All 5 trials loaded